If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJp Morg.as Regulatory News (JAGI)

Share Price Information for Jp Morg.as (JAGI)

Share Price is delayed by 15 minutes
Get Live Data
598.00    -20.00 (-3.24%)
Bid:
594.00
Ask:
600.00
Spread: 6.00 (1.01%)
Market Cap: £402.59m
JAGI Live PriceLast checked at - London Stock Exchange

Intraday Jp Morg.as Share Chart

Initiation from QuotedData

5 Aug 2025 14:04

RNS Number : 0845U
JPMorgan Asia Growth & Income PLC
05 August 2025
 

JPMorgan Asia Growth and Income - Initiation from QuotedData

5th August 2025

Asain income without compromising on growth

JPMorgan Asia Growth and Income (JAGI) has a solid long-term track record of outperformance of its benchmark (the MSCI All Countries Asia ex Japan index), helped by its focus on maximising long-term total returns. In February 2025, the trust introduced an even more enhanced dividend policy, that delivers an attractive level of income without compromising on the manager's ability to pick the best stocks for the portfolio, which should help maintain the trust's long-term capital growth potential.

Considerable effort is being made to moderate the volatility of JAGI's share price discount to NAV with the use of share buybacks, and that appears to be working well. We see scope for increased demand for the trust and potentially a narrowing of the discount as investors come to appreciate the new dividend. The region could also benefit as investors consider reallocating funds from the US to other, faster-growing regions such as Asian markets, many of which exhibit more favourable demographic trends and economic growth prospects.

Full Research:

https://quoteddata.com/research/jpmorgan-asia-growth-and-income-asian-income-without-compromising-on-growth-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note JPMorgan Asian Growth & Income Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSLFEIEISEIA
Date   Source Headline
16th Sep 20245:01 pmRNSTransaction in Own Shares
16th Sep 202411:33 amRNSGearing announcement
16th Sep 202410:51 amRNSNet Asset Value(s)
13th Sep 20245:03 pmRNSTransaction in Own Shares
13th Sep 20243:59 pmRNSHolding(s) in Company
13th Sep 202410:54 amRNSNet Asset Value(s)
12th Sep 20245:07 pmRNSTransaction in Own Shares
12th Sep 202410:37 amRNSNet Asset Value(s)
11th Sep 20245:08 pmRNSTransaction in Own Shares
11th Sep 202411:12 amRNSTen Largest Investments
11th Sep 202410:29 amRNSNet Asset Value(s)
10th Sep 20245:05 pmRNSTransaction in Own Shares
10th Sep 202410:42 amRNSNet Asset Value(s)
10th Sep 202410:36 amRNSHolding(s) in Company
9th Sep 20245:09 pmRNSTransaction in Own Shares
9th Sep 202412:00 pmRNSGearing Announcement
9th Sep 202410:59 amRNSNet Asset Value(s)
6th Sep 20245:11 pmRNSTransaction in Own Shares
6th Sep 202410:55 amRNSNet Asset Value(s)
5th Sep 20245:03 pmRNSTransaction in Own Shares
5th Sep 202410:42 amRNSNet Asset Value(s)
4th Sep 20244:59 pmRNSTransaction in Own Shares
4th Sep 202410:49 amRNSNet Asset Value(s)
3rd Sep 20245:19 pmRNSTransaction in Own Shares
3rd Sep 202411:21 amRNSNet Asset Value(s)
2nd Sep 20245:09 pmRNSTransaction in Own Shares
2nd Sep 20242:01 pmRNSGearing Announcement
2nd Sep 202412:09 pmRNSNet Asset Value(s)
2nd Sep 20249:18 amRNSTotal Voting Rights
30th Aug 20245:03 pmRNSTransaction in Own Shares
30th Aug 202411:27 amRNSNet Asset Value(s)
29th Aug 20245:10 pmRNSTransaction in Own Shares
29th Aug 202410:49 amRNSNet Asset Value(s)
29th Aug 202410:28 amRNSDirector/PDMR Shareholding
28th Aug 20245:01 pmRNSTransaction in Own Shares
28th Aug 202411:07 amRNSNet Asset Value(s)
27th Aug 20245:06 pmRNSTransaction in Own Shares
27th Aug 20241:01 pmRNSGearing Announcement
27th Aug 202411:59 amRNSNet Asset Value(s)
23rd Aug 202410:41 amRNSNet Asset Value(s)
22nd Aug 20245:05 pmRNSTransaction in Own Shares
22nd Aug 202410:22 amRNSNet Asset Value(s)
21st Aug 20245:00 pmRNSTransaction in Own Shares
21st Aug 20243:48 pmRNSNAMING OF ADDITIONAL PORTFOLIO MANAGER
21st Aug 202410:23 amRNSNet Asset Value(s)
20th Aug 20244:51 pmRNSTransaction in Own Shares
20th Aug 202410:57 amRNSNet Asset Value(s)
19th Aug 202411:48 amRNSGearing Announcement
19th Aug 202411:05 amRNSNet Asset Value(s)
16th Aug 20245:09 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.